hotspot -WSS

hotspot

author：focus 2025-10-02 11:07:53 - browse：696

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： HIV vaccine remains elusive. Immunologists keep trying new ideas

explore

WSS

MoonLake credibility takes another hit with mid

Just how powerful is the placebo effect?

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Criminal prosecution for violating HIPAA: an emerging threat

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Free speech concerns arise in wake of journal editor Eisen's firing

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Cancer drug shortages should be causing more outrage

Medicare will require more price transparency from hospitals

ChatGPT in medicine: STAT answers readers' burning questions

Free speech concerns arise in wake of journal editor Eisen's firing

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Venture capitalist Bob Kocher on the state of digital health

After affirmative action ruling, medical educators look to 'holistic review'

FDA approves Recor Medical high blood pressure device

Moonlake's readout produced a cash windfall. Risks remain

Bird flu: Don't repeat Covid's 'health versus the economy' framing

explore

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

FDA approves Recor Medical high blood pressure device

Military medical care influenced by rank and race, new study finds

Excited delirium, Elijah McClain, and emergency physicians

More doctors should go into startup world

knowledge

leisure time

explore

knowledge